Literature DB >> 4426045

Phase II study of dibromodulcitol (NSC-104800).

N C Andrews, A J Weiss, W Wilson, T Nealon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4426045

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN： 0069-0112


× No keyword cloud information.
  2 in total

1.  Dibromodulcitol plus bleomycin compared with bleomycin alone in head and neck cancer.

Authors:  B F Issell; G Borsos; J C D'Aoust; F Banhidy; S T Crooke; S Eckhardt
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

2.  Phase II evaluation of dibromodulcitol and actinomycin D, hydroxyurea, and cyclophosphamide in previously untreated patients with malignant melanoma.

Authors:  D A Amato; H Bruckner; D Guerry; A Ash; G Falkson; E C Borden; R H Creech; E D Savlov; T J Cunningham
Journal:  Invest New Drugs       Date:  1987       Impact factor: 3.850
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.